Literature DB >> 21932594

Clinical characteristics of adrenocortical tumors in children.

Qiu-Li Chen1, Zhe Su, Yan-Hong Li, Hua-Mei Ma, Hong-Shan Chen, Min-Lian Du.   

Abstract

BACKGROUND: Adrenocortical tumors (ACTs) are rare in children. Because of the rarity and various manifestations of ACTs, patients of ACTs are not easily diagnosed. Some patients were misdiagnosed before surgery.
OBJECTIVE: Identify the clinical, laboratorial, imaging and histopathological characteristics of adrenocortical tumors in children. Compare adrenalcortical adenoma with carcinoma.
METHODS: A retrospective review of 34 identified patients who were younger than 15 years old with histologic confirmation of adrenocortical carcinoma (ACC) or adenomas from 1991 to 2010.
RESULTS: In these 34 patients, 19 were adrenocortical adenoma (ACA) and 15 were ACC. The median age at diagnosis was 3.33 years (range, 0-16 years), and 70.6% of the patients were younger than five years. Girls slightly predominated over boys (1.4:1). For endocrine abnormality, 14 patients had isolated precocious puberty, five patients had isolated Cushing syndrome, 10 patients had precocious puberty plus Cushing syndrome, and five patients did not have any symptoms. The most frequent findings in laboratory tests were disturbance of the normal circadian rhythm of cortisol secretion (93.8%), followed by elevated serum level of testosterone (89.7%). Only 3.8% of ultrasound diagnosis and 12.1% of computed tomography (CT) diagnosis were consistent with pathologic diagnosis.
CONCLUSION: Different from those in adult, the most frequent presentation in children with ACTs is peripheral precocious puberty with or without Cushing syndrome, and isolated Cushing syndrome. Few present with non-functional local mass. Laboratory tests usually reveal the discordantly elevated serum levels of sexual corticosteroid hormones, change of diurnal rhythm of cortisol or increase of morning cortisol. The differentiation of malignant from benign tumor cannot merely depend on imaging. Final diagnosis relies on comprehensive evaluation of clinical manifestations, laboratory data, imaging and pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21932594     DOI: 10.1515/jpem.2011.175

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

1.  Management and prognosis of adrenocortical tumors in children: can we find out an appropriate points-scoring system to predict prognosis?

Authors:  Wei Ru; Min Yang; Shan Xu; Minju Li; Daxing Tang
Journal:  Pediatr Surg Int       Date:  2017-03-04       Impact factor: 1.827

Review 2.  Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease.

Authors:  Christina Tatsi; Constantine A Stratakis
Journal:  Clin Perinatol       Date:  2017-12-12       Impact factor: 3.430

3.  Precocious puberty--perspectives on diagnosis and management.

Authors:  P S N Menon; M Vijayakumar
Journal:  Indian J Pediatr       Date:  2013-09-07       Impact factor: 1.967

4.  Clinical characteristics of adrenal tumors in children: a retrospective review of a 15-year single-center experience.

Authors:  Xiaokun Lin; Dazhou Wu; Congde Chen; Na Zheng
Journal:  Int Urol Nephrol       Date:  2016-12-17       Impact factor: 2.370

Review 5.  Adrenocortical carcinoma: Pediatric aspects (Review).

Authors:  Florica Sandru; Răzvan-Cosmin Petca; Mara Carsote; Aida Petca; Mihai Cristian Dumitrascu; Adina Ghemigian
Journal:  Exp Ther Med       Date:  2022-02-16       Impact factor: 2.447

6.  Feminizing adrenocortical adenoma in a girl from a resource-limited setting: a case report.

Authors:  Eman Abdalla Ali Elnaw; Areej Ahmed Bashier Ibrahim; Mohamed Ahmed Abdullah
Journal:  J Med Case Rep       Date:  2021-12-21

7.  Need for comprehensive hormonal workup in the management of adrenocortical tumors in children.

Authors:  E Nazlı Gönç; Zeynep Alev Özön; Meltem Didem Cakır; Ayfer Alikaşifoğlu; Nurgün Kandemir
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.